Table 2. Characterizations of patients having pol and env sequences with potential recombinants.

No.	Sex	Route of transmission	HAART regimens	Months post-HAART	CD4+ T cells/µl	Plasma HIVRNA copies/ml	Subtype pol(simplot)	Subtype env(tree)
339	Male	Heterosexual	D4T+3TC+EFV	37.4	234	<50	CRF02_AG	CRF01_AE
203	Male	IDU	D4T+3TC+EFV	43.3	265	100000	CRF07_BC	CRF01_AE
197	Male	Heterosexual	None		181	40000	CRF08_BC	B
34	Male	IDU	AZT+3TC+NVP	26.9	308	<50	URF (A/C/A)	A
40	Male	Heterosexual	D4T+3TC+NVP	0.5	222	96	URF (CRF02_AG/CRF01_AE)	CRF02_AG